Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
4,503,909
-
Total 13F shares
-
4,743,321
-
Share change
-
-1,607,787
-
Total reported value
-
$1,914,000
-
Price per share
-
$0.40
-
Number of holders
-
24
-
Value change
-
-$711,862
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q2 2022
As of 30 Jun 2022,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,743,321 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., AIGH Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, Maven Securities LTD, ACT CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Bank of New York Mellon Corp, and FRANKLIN RESOURCES INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.